Ameriprise
BIOA

Ameriprise’s BioAge Labs BIOA Stock Holding History

Ameriprise’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
59,198
+65
+0.1% +$1.17K ﹤0.01% 3235
2026
Q1 		$1.03M Sell
59,133
-23,830
-29% -$459K ﹤0.01% 3285
2025
Q4 		$1.1M Buy
82,963
+52,500
+172% +$465K ﹤0.01% 3284
2025
Q3 		$179K Sell
30,463
-13,571
-31% -$63.5K ﹤0.01% 3918
2025
Q2 		$182K Buy
+44,034
New +$177K ﹤0.01% 3826

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Ameriprise's BIOA Position: Q2 2026 in Review

Ameriprise increased its BioAge Labs (BIOA) stake by 0.11% in Q2 2026, buying an estimated $1.17K and bringing the position to 59,198 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3235.

Ameriprise first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Ameriprise held 59,198 shares of BioAge Labs worth $1.45M as of Q2 2026.
  • Ameriprise bought 65 BioAge Labs shares in Q2 2026, an estimated $1.17K.
  • BioAge Labs made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3235 holding.
  • Ameriprise first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.